3+ day, 16+ hour ago   (576+ words) Industry leaders emphasized that accelerating clinical research must go hand in hand with sustained, community-driven strategies to advance diversity, equity, and inclusion in clinical trials. "Scientific excellence depends on making sure that the people who are most in need of…...

3+ day, 20+ hour ago   (280+ words) Holly Leslie, vice president of services at Ledger Run, explains why site selectivity is not yet universal, but increasingly driven by larger, more sophisticated sites that are demanding stronger remuneration policies and greater leverage in sponsor relationships. In a video…...

3+ day, 20+ hour ago   (677+ words) Ken Getz of Tufts CSDD and Eliav Barr of Merck discuss how efficiency, public trust, and AI all fit into the current state of clinical research. The first full day of SCOPE Summit 2026 kicked off with a keynote fireside chat…...

4+ day, 12+ hour ago   (487+ words) Industry leaders explore areas of opportunity for acceleration as well as how early-phase planning, technology, and collaboration can keep moving the clinical ecosystem forward. Efficiency and accelerating clinical trial timelines have emerged as key themes at this year's annual SCOPE…...

6+ day, 1+ hour ago   (1043+ words) As clinical trials grow increasingly complex, the biopharmaceutical research industry faces a number of unprecedented pressures that are shifting the way outsourcing models are deployed. Sponsors are confronting macroeconomic headwinds: increased demand to accelerate cycle times, mounting cost pressures, and…...

1+ week, 2+ day ago   (280+ words) ACT Brief: FDA Capacity Strains Timelines, Sponsors Rethink Site Support, and Regulators Align on AI'Applied Clinical Trials Online This is the Applied Clinical Trials Brief'your fast track to the latest insights shaping clinical operations and drug development. In a new…...

1+ week, 4+ day ago   (533+ words) The FDA and EMA have aligned on ten guiding principles for the responsible use of artificial intelligence across the drug development lifecycle, establishing a shared framework to support innovation, regulatory consistency, and patient safety. "Regulators have been very clear in…...

1+ week, 6+ day ago   (265+ words) ACT Brief: Decentralized Innovation Faces Reality, RWE Finds Its Lane, and Clinical Ops Reset for 2026Applied Clinical Trials Online This is the Applied Clinical Trials Brief'your fast track to the latest insights shaping clinical operations and drug development. In a new…...

1+ week, 6+ day ago   (668+ words) A look at how efficiency, access, platformization, AI, non-traditional players, and regulatory recovery are expected to reshape clinical operations in 2026. Over the past year, sponsors have pushed aggressively to improve efficiency across feasibility, site selection, and enrollment, increasingly relying on…...

2+ week, 3+ day ago   (225+ words) Examine how the FDA's acceptance of de-identified real-world evidence shifts clinical operations workflows and why understanding the difference between pseudonymized and anonymized data is now critical for privacy, compliance, and evidence generation. Editor's note: This transcript is a lightly edited…...